FDA Warning Letter — NeuroSync, Inc.
The FDA took a Warning Letter action against NeuroSync, Inc. on July 31, 2017 (Holliston, MA). The action was issued by CDRH and concerns devices products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- NeuroSync, Inc.
- Date
- July 31, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Center
- CDRH
- Location
- Holliston, MA (United States)